# Alzamend Neuro submits IND application for a Phase IIa clinical trial in major depressive disorder patients of its lithium therapeutics drug candidate...
**FDA Update**

**2023-10-23 11:40**

**https://www.ainvest.com/news/alzamend-neuro-submits-ind-application-for-a-phase-iia-clinical-trial-in-major-depressive-disorder-patients-of-its-lithium-therapeutics-drug-candidate-al001-benzinga-23101000955a152aff827a3c/**

Alzamend Neuro submits IND application for a Phase IIa clinical trial in major depressive disorder patients of its lithium therapeutics drug candidate Al001 - Benzinga